IMUNON, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.27 USD | -3.79% |
|
-11.81% | +86.76% |
| Jun. 05 | IMUNON, Inc. Announces First Participants Vaccinated in IMNN-101 Phase 1 Clinical Trial | CI |
| May. 20 | Imunon, Inc. Announces CFO Changes, Effective from June 1, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IMUNON, INC. | Bio Therapeutic Drugs | -3.79% | -11.81% | +86.76% | 0.00% | -95.47% | 11.94M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- IMNN Stock
- Charts Imunon, Inc.
- Comparison Chart
